Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
AMR will require more than another round of promising compounds: the antibiotics that are most needed do not provide the ...
It should be motoring to profitability, but nine months after the U.S. launch of its new antibiotic, Zemdri (plazomicin), Achaogen Inc. has filed for chapter 11 bankruptcy and is now selling off its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results